Asthma Treatment & Management Guidelines, Symptoms, Classification, Types, Medicine Lecture USMLE

MedNerd - Dr. Waqas Fazal
8 Oct 202225:06

Summary

TLDRThis video lecture discusses asthma, a chronic respiratory condition marked by reversible airflow obstruction and bronchial inflammation. It covers the triggers, clinical presentation, and diagnosis using pulmonary function tests. The script also explains the classification of asthma and its step-by-step treatment, including the use of inhalers and bronchodilators. Additionally, it addresses general measures, follow-up, and side effects of medications.

Takeaways

  • πŸŒͺ️ Asthma is a chronic inflammatory disease of the respiratory system characterized by reversible air flow obstruction, bronchial hyper responsiveness, and inflammation.
  • 🌿 Extrinsic asthma is allergic in nature, often triggered by allergens like pollens, dust mites, and pet dander, while intrinsic asthma is non-allergic and can be triggered by viral infections or cold air.
  • 🚫 Certain medications like beta blockers and NSAIDs can induce asthma symptoms due to their effects on bronchoconstriction.
  • πŸ‘Ά Children exposed to second-hand smoke are at an increased risk of developing asthma.
  • πŸ”Š Clinical presentation of asthma includes symptoms like persistent dry cough, shortness of breath, and chest tightness, with wheezing heard upon auscultation.
  • πŸ“ˆ Spirometry, a type of pulmonary function test, is crucial for diagnosing asthma by measuring forced expiratory volume in one second (FEV1) and forced vital capacity (FVC).
  • 🌑 Bronchial provocation tests, though not commonly performed, can provoke bronchoconstriction to confirm asthma diagnosis in patients with normal spirometry results.
  • πŸ’Š Treatment for asthma includes short-acting beta agonists (SABA) for rescue and inhaled corticosteroids (ICS) combined with long-acting beta agonists (LABA) for maintenance.
  • πŸ“‰ Asthma is classified into intermittent, mild persistent, moderate persistent, and severe persistent based on symptom frequency and severity.
  • πŸ’‰ Oral corticosteroids are reserved for severe persistent asthma that is not controlled with inhaler therapy due to their significant side effects.
  • πŸ›‘ Smoking cessation is critical for asthma patients as it can exacerbate symptoms and is a primary preventive measure.

Q & A

  • What is asthma?

    -Asthma is a chronic inflammatory disease of the respiratory system characterized by reversible air flow obstruction, bronchial hyper responsiveness, and bronchial inflammation.

  • What are the key features of asthma?

    -The key features of asthma include airflow obstruction that is reversible, episodic, and accompanied by hyper responsiveness of bronchi and bronchioles, leading to constriction and inflammation.

  • How is asthma classified based on triggers?

    -Asthma is divided into two categories based on triggers: extrinsic asthma, which is mainly allergic, and intrinsic asthma, which is non-allergic and often triggered by viral infections or cold air.

  • What are common triggers for extrinsic asthma?

    -Common triggers for extrinsic asthma include allergens like pollens, dust mites, pets, and floor dust.

  • What is the prognosis for extrinsic asthma?

    -Extrinsic asthma, also known as allergic asthma, generally has a good prognosis.

  • What are the clinical presentations of asthma?

    -Clinical presentations of asthma include persistent dry cough, shortness of breath, chest tightness, and wheezing due to bronchiole constriction.

  • How is asthma diagnosed?

    -Asthma is diagnosed through typical clinical features like dry cough, difficulty breathing, chest tightness, and wheezes, along with demonstration of reversible bronchoconstriction through tests like pulmonary function tests (PFTs) and spirometry.

  • What is the difference between COPD and asthma on spirometry?

    -Both COPD and asthma can show a decrease in FEV1/FVC ratio on spirometry, but COPD patients usually have a baseline obstruction, whereas asthma patients may have normal spirometry results between attacks.

  • What is the significance of bronchodilator reversibility test?

    -The bronchodilator reversibility test is used to differentiate between COPD and asthma. In asthma, there is typically a greater than 12% increase in forced expired volume in the first second (FEV1) after bronchodilator administration, whereas COPD patients show little to no improvement.

  • How is asthma classified according to the National Asthma Education and Prevention Program?

    -According to the National Asthma Education and Prevention Program, asthma is classified into intermittent asthma and persistent asthma, with the latter further divided into mild persistent, moderate persistent, and severe persistent asthma based on symptom frequency and severity.

  • What is the treatment for intermittent asthma?

    -Intermittent asthma is treated with short-acting beta-agonist (SABA) inhalers as needed for relief, with daily therapy not typically required. However, the 2020 GINA guidelines recommend considering the addition of low-dose inhaled corticosteroids for daily therapy.

  • What are the potential side effects of inhaled corticosteroids used in asthma treatment?

    -Potential side effects of inhaled corticosteroids include oral candidiasis, which is why patients are advised to rinse their mouth after use. Other side effects of systemic corticosteroids include diabetes mellitus, cataracts, osteoporosis, and adrenal suppression.

Outlines

00:00

🌬️ Understanding Asthma

The script begins by explaining asthma as a chronic inflammatory disease of the respiratory system. It highlights the features of asthma, including reversible air flow obstruction, bronchial hyper-responsiveness, and inflammation. The triggers for asthma are discussed, dividing asthma into extrinsic (allergic) and intrinsic (non-allergic) types. Extrinsic asthma is often linked to allergies to pollens, dust mites, and pets, while intrinsic asthma can be triggered by viral infections and cold air. The script also touches on how certain medications, like beta blockers and NSAIDs, can induce asthma symptoms. The importance of family history and exposure to second-hand smoke in the development of asthma is also mentioned.

05:00

πŸ” Clinical Presentation and Diagnosis

This section delves into the clinical presentation of asthma, such as persistent dry cough, shortness of breath, and chest tightness. It explains the physical signs of asthma, like wheezing and hyper resonance in the lungs. The diagnosis process is outlined, emphasizing the use of pulmonary function tests (PFTs), particularly spirometry, to measure forced expiratory volume in one second (FEV1) and the FEV1/FVC ratio. The script also discusses how asthma can present differently, with some patients having normal lung function tests outside of an attack. Bronchial provocation tests are mentioned as a method to provoke bronchoconstriction for diagnostic purposes, although they are not commonly performed due to risks associated with severe asthma.

10:02

πŸ₯ Differentiating Asthma from COPD

The script addresses how to differentiate asthma from COPD on spirometry results, noting that both conditions can show a decreased FEV1/FVC ratio. It points out that COPD patients typically have a baseline obstruction, whereas asthma patients may have normal lung function between attacks. The use of bronchodilator reversibility tests is introduced as a method to distinguish between the two, where a significant increase in FEV1 after bronchodilator use suggests asthma. The classification of asthma by the National Asthma Education and Prevention Program is also covered, outlining intermittent, mild persistent, moderate persistent, and severe persistent asthma.

15:03

πŸ’Š Treatment Approaches for Asthma

This part of the script discusses the treatment of asthma, starting with intermittent asthma and moving through mild, moderate, and severe persistent asthma. It details the use of short-acting beta-agonists (SABA) like albuterol for rescue therapy and the addition of low-dose inhaled corticosteroids for daily therapy in mild persistent asthma. For moderate and severe persistent asthma, the script describes the use of long-acting beta-agonists (LABA) in combination with inhaled corticosteroids, leukotriene receptor antagonists, and long-acting muscarinic antagonists. The importance of patient compliance, proper inhaler technique, and the use of spacers is emphasized. The script also cautions about the side effects of medications used in asthma treatment.

20:05

πŸ“ˆ Managing and Monitoring Asthma

The final section focuses on the management and monitoring of asthma. It stresses the importance of medication review, avoiding allergens, treating comorbidities, and smoking cessation. The use of peak flow meters for patients to monitor their lung function at home is introduced. The script also discusses the importance of follow-up visits to assess symptom frequency and lung function, and the possibility of step-down therapy if the patient is stable. It addresses the inadequate response to treatment, the need for compliance checks, and the proper use of inhalers. The side effects of inhaled corticosteroids and oral corticosteroids are mentioned, along with historical notes on the use of grimald cigarettes, which contained atropine and cannabis, as a treatment for asthma in the past.

Mindmap

Keywords

πŸ’‘Asthma

Asthma is a chronic inflammatory disease of the respiratory system characterized by reversible air flow obstruction, bronchial hyper-responsiveness, and bronchial inflammation. It is the central theme of the video, which discusses its presentation, diagnosis, and treatment. The script mentions that asthma is episodic and reversible, with symptoms like wheezing and shortness of breath that can be triggered by allergens or viral infections.

πŸ’‘Reversible Airflow Obstruction

Reversible airflow obstruction refers to the temporary narrowing of the airways that can be reversed with treatment, a key feature of asthma. The script explains that in asthma, the bronchioles constrict, causing difficulty in breathing, which is episodic and reversible, as seen in the comparison of normal bronchioles versus those in asthma.

πŸ’‘Bronchial Hyper-responsiveness

Bronchial hyper-responsiveness is a state where the bronchi and bronchioles are more sensitive and react strongly to various triggers, leading to constriction. The script mentions that this hyper-responsiveness is a characteristic of asthma, causing the airways to constrict upon exposure to allergens or cold air.

πŸ’‘Extrinsic Asthma

Extrinsic asthma, also known as allergic asthma, is a type of asthma triggered by allergens such as pollens, dust mites, and pet dander. The script describes it as the main form of allergic asthma, where patients develop bronchial constriction and inflammation upon exposure to these allergens.

πŸ’‘Intrinsic Asthma

Intrinsic asthma is a non-allergic form of asthma, often triggered by factors like viral infections or cold air. The script explains that unlike extrinsic asthma, intrinsic asthma does not have an allergic basis and is more common in children and individuals with GERD.

πŸ’‘Pulmonary Function Tests (PFTs)

Pulmonary function tests are diagnostic tools used to measure lung capacity and airflow, which are crucial in diagnosing asthma. The script discusses how PFTs, specifically spirometry, can demonstrate reversible bronchoconstriction by measuring the forced expiratory volume in one second (FEV1) and comparing it to the forced vital capacity (FVC).

πŸ’‘Spirometry

Spirometry is a type of pulmonary function test that measures how much air a person can exhale, and how quickly they can exhale it. The script describes spirometry as a main test for diagnosing asthma by assessing the FEV1 and the FEV1/FVC ratio, which are indicative of airway obstruction.

πŸ’‘Bronchodilator

A bronchodilator is a medication that relaxes the muscles in the airways, increasing airflow. The script mentions the use of bronchodilators like albuterol in treating asthma attacks by causing bronchodilation and providing relief from symptoms.

πŸ’‘Inhaled Corticosteroids

Inhaled corticosteroids are medications used to reduce inflammation in the airways and are a cornerstone of asthma treatment. The script discusses their use in daily therapy for persistent asthma, with examples such as budesonide and fluticasone, to control inflammation and prevent asthma attacks.

πŸ’‘Status Asthmaticus

Status asthmaticus is a severe and continuous asthma attack that does not respond to initial treatment. The script briefly mentions it in the context of the risks associated with bronchial provocation tests and refers to a separate video detailing its management.

πŸ’‘Peak Flow Meter

A peak flow meter is a device used to measure the speed of airflow out of the lungs, which can help monitor asthma control. The script advises teaching patients to use a peak flow meter to track their lung function and the effectiveness of their asthma treatment at home.

Highlights

Asthma is a chronic inflammatory disease of the respiratory system characterized by reversible air flow obstruction.

Asthma is divided into extrinsic (allergic) and intrinsic (non-allergic) categories based on triggers.

Extrinsic asthma often has a good prognosis and is associated with a family history of atopy.

Intrinsic asthma can be triggered by viral infections and is often linked to GERD.

Children exposed to second-hand smoke have an increased risk of developing asthma.

Asthma symptoms include persistent dry cough, shortness of breath, and chest tightness.

Pulmonary function tests, specifically spirometry, are crucial for diagnosing asthma.

Asthma diagnosis can be confirmed with a decrease in FEV1/FVC ratio on spirometry.

Bronchial provocation tests can be used to diagnose asthma in patients with normal spirometry results.

Asthma is classified into intermittent, mild persistent, moderate persistent, and severe persistent categories.

Intermittent asthma is characterized by symptoms less than twice a week and no daily activity limitations.

Mild persistent asthma is treated with low-dose inhaled corticosteroids and short-acting beta-agonists.

Moderate persistent asthma requires a combination of inhaled corticosteroids and long-acting beta-agonists.

Severe persistent asthma may necessitate the addition of oral corticosteroids to inhaled therapies.

General measures for asthma patients include medication review, allergen avoidance, and smoking cessation.

Teaching patients the use of peak flow meters can help monitor asthma symptoms at home.

Inhaled corticosteroids can cause oral candidiasis, and patients should rinse their mouths after use.

An interesting historical note is that Grimald cigarettes, containing atropine and cannabis, were once prescribed for asthma.

Transcripts

play00:00

okay in our video series of pulmonology

play00:03

lectures in this video we are going to

play00:05

talk about asthma we are going to

play00:06

discuss the presentation and diagnosis

play00:08

of asthma we are going to discuss it how

play00:10

do you treat a patient of asthma step by

play00:13

step first of all asthma is a chronic

play00:16

inflammatory disease of respiratory

play00:18

system characterized by reversible air

play00:20

flow obstruction

play00:21

and bronchial hyper responsiveness and

play00:25

bronchial inflammation so there are

play00:28

three main important things that there

play00:30

is airflow obstruction blood that

play00:32

airflow obstruction is reversible that

play00:34

airflow obstruction is episodic and

play00:37

there is hyper responsiveness of bronchi

play00:40

and bronchioles so the bronchioles

play00:42

constrict and there is inflammation of

play00:45

the bronchioles this is a picture

play00:48

showing normal bronchioles look at the

play00:51

normal dilated bronchioles and this is

play00:54

the picture showing bronchioles in

play00:56

asthma where they are constricted they

play00:59

are red they are inflamed and that

play01:01

happens episodically that is reversible

play01:05

now coming to the triggers of asthma on

play01:07

the basis of the triggers of asthma

play01:09

asthma is divided into two categories

play01:11

extrinsic and intrinsic asthma extrinsic

play01:14

asthma is mainly the allergic asthma and

play01:17

patients are allergic to pollens dust

play01:19

mites pets floor dust patients whenever

play01:23

they are exposed to these things they

play01:26

develop bronchial constriction they

play01:29

develop inflammation of the bronchi they

play01:31

get difficulty in breathing they develop

play01:33

visas in their chest they're allergic to

play01:36

these things these are the people who

play01:37

also have a history of atop these people

play01:40

have members in their family who are

play01:42

also allergic to many things they have a

play01:44

family history of etopy and remember

play01:47

extrinsic asthma allergic asthma has a

play01:50

good prognosis

play01:52

the other category includes intrinsic

play01:54

asthma in intrinsic asthma it is

play01:56

non-allergic

play01:57

and most common cause of non-allergic

play02:00

asthma is viral infection especially in

play02:02

the children cold air can induce known

play02:06

allergic or intrinsic asthma exposure to

play02:10

cold air causes constriction of the

play02:12

bronchiole inflammation and resulting in

play02:15

asthma

play02:16

these patients usually have Gerd asthma

play02:19

patients are three times more likely to

play02:21

develop gerd because this acid reflux it

play02:26

irritates the bronchial Airways when it

play02:28

irritates the bronchial Airway it causes

play02:29

constriction

play02:31

medications like beta blockers NSAIDs

play02:34

can also cause asthma beta blockers

play02:37

block The beta2 receptors and they cause

play02:40

bronchoconstriction that's why we use

play02:42

beta agonists for the treatment NSAIDs

play02:45

can also cause bronchoconstriction

play02:47

NSAIDs cause increase in leukotriene

play02:49

levels which cause bronchoconstriction

play02:51

so this is extrinsic asthma which is

play02:54

allergic intrinsic eczema which is

play02:55

non-allergic an important point to

play02:58

remember is that children who have

play03:01

exposure to second-hand smoke have

play03:04

increased risk of developing asthma

play03:07

now coming to the clinical presentation

play03:10

of asthma whenever a patient with asthma

play03:12

is exposed to these agents that

play03:15

triggered asthma they develop persistent

play03:17

dry cough they develop shortness of

play03:19

breath they develop chest tightness

play03:21

because the bronchioles have now

play03:24

constricted when the bronchioles have

play03:26

constricted it's difficult for the air

play03:28

to get out of the lungs it is an

play03:30

obstructive disease therefore you will

play03:32

listen to and expiratory weasels there

play03:35

will be visas at the end of expression

play03:37

because it is difficult for the air to

play03:39

get out of the lungs and when it is

play03:41

difficult for the air to get out of the

play03:43

lungs air will accumulate in there and

play03:46

there will be hyper resonance the lungs

play03:48

will be hyper resonant now this is how

play03:52

the VZ chest sounds like whenever you

play03:54

put stethoscope on the chest of a person

play03:57

who is suffering from asthmatic attack

play03:58

this is how the chest sounds like

play04:11

this is not how a normal chest sounds

play04:13

like these are the whises that are

play04:15

present in the chest you can put the

play04:17

stethoscope on your own chest and listen

play04:19

to the normal breath sounds and then

play04:21

compare it with this audio these are all

play04:23

the Visas because it is difficult for

play04:26

the air to get out of the lungs now

play04:28

coming to the diagnosis of asthma in the

play04:30

diagnosis of asthma if the patient's age

play04:32

is greater than or equal to five years

play04:34

of age if the patient has typical

play04:36

clinical features of asthma dry cough

play04:39

difficulty breathing chest tightness

play04:42

wheezes and with that there is

play04:44

demonstration of reversible

play04:45

bronchoconstriction how do you do that

play04:48

you do that with tests like pfts

play04:51

pulmonary function tests are the main

play04:53

tests for diagnosis of asthma in

play04:55

pulmonary function test there is a test

play04:57

called a spirometry in spirometry what

play05:00

you do is that you ask the patient to

play05:02

take a full breath and then exhale

play05:06

through mouth into this device this

play05:09

device is a part of spirometer and that

play05:12

spirometer detects that how much a

play05:15

person can exhale and with which speed

play05:17

they can exhale now if the patient is

play05:20

having asthma that patient would not be

play05:22

able to Exhale air out easily because

play05:26

there is obstruction because there is

play05:28

bronchoconstriction so the forced

play05:31

expiratory volume in the first second it

play05:35

detects the force expiratory volume in

play05:37

the first second and that volume of air

play05:39

that that patient exhales will be less

play05:41

than a normal person and we also

play05:45

calculate the ratio of force expiratory

play05:47

volume 1 with forced vital capacity the

play05:50

capacity of air that a person can

play05:52

normally exhale is called as forced

play05:54

vital capacity and that ratio is also

play05:57

decreased

play05:58

so a normal person can exhale air easily

play06:02

without any difficulty but a patient

play06:04

with asthma has to Exhale the air out

play06:07

with difficulty due to the

play06:08

bronchoconstriction therefore fev1 will

play06:10

be less now sometime it happens that a

play06:14

patient comes to you and tells you the

play06:15

doctor I get difficulty breathing

play06:17

sometime I get chest tightness I

play06:20

sometimes experience dry cough

play06:21

difficulty breathing but when you

play06:24

examine the patient patient at that

play06:26

point in time is totally normal

play06:28

why this is because that as I said that

play06:31

asthma is a reversible disease sometimes

play06:34

the patient is in a very bad condition

play06:37

patient is experiencing just tightness

play06:39

difficulty breathing but after some time

play06:41

the patient is totally fine all the

play06:43

tests are normal the examination is

play06:45

normal there are no findings because it

play06:48

is a reversible disease so patient has a

play06:51

normal Baseline Health but sometimes he

play06:54

experiences bronchoconstriction and

play06:56

exacerbation of asthma now that patient

play06:59

is having a total normal examination if

play07:02

you go for fev1 FEC at that time when

play07:05

the patient is not having an anasma

play07:07

attack the patient's fev1 will be normal

play07:09

the feb1 FEC ratio will also be normal

play07:12

in that case if you are suspecting that

play07:15

that patient has asthma then bronchial

play07:17

provocation tests are done

play07:19

bronchial provocation tests are the

play07:22

tests that provoke the

play07:24

bronchoconstriction

play07:25

they give certain agents like

play07:27

methylcholine

play07:29

that methacholine is given in a

play07:31

concentration that if it is given to a

play07:33

normal person normal person would not

play07:35

experience that much bronchoconstriction

play07:37

but if it is given to an asthmatic

play07:39

patient asthmatic patient would cause

play07:41

severe bronchoconstriction and you will

play07:44

detect that on spirometry you repeat

play07:46

spirometry after given giving

play07:48

methylcholine and you detect a decrease

play07:51

in fev1 and fvc

play07:53

but remember that these tests are also

play07:57

risky if a patient is a severe asthmatic

play07:59

patient and the spirometry came out to

play08:01

be normal and you plan to go for

play08:03

bronchial provocation test sometimes

play08:06

there is a risk that that patient can

play08:07

develop status asthmaticus now in real

play08:10

life these bronchial provocation tests

play08:12

are not as commonly performed because

play08:13

sometimes the patient are having severe

play08:16

asthma and they are coming to you in a

play08:18

state where they are totally fine they

play08:19

are totally normal but to diagnose you

play08:22

give methylcholine and it causes severe

play08:24

bronchoconstriction anyone state of

play08:25

systematicus so methylcholine challenges

play08:28

just for remember them for academic

play08:30

purposes but in real life these tests

play08:32

are not commonly performed what you can

play08:35

do is that you can ask the patient to do

play08:37

some exercise if the spirometer is

play08:39

totally normal you can ask the patient

play08:40

to do some exercise and if there is some

play08:42

cold air some cold temperature in that

play08:44

cold air if the patient does some

play08:46

exercise then there can be slight

play08:47

bronchoconstriction and you can see a

play08:49

decrease in the levels of spirometry

play08:53

so if a patient comes to you with an

play08:54

estimatic attack you can do spirometry

play08:57

in that case the spirometry will show

play08:59

decrease in fev1 to FCC ratio but if the

play09:01

patient is not experiencing as estimatic

play09:03

attack at that point when it comes to

play09:04

you in your clinic

play09:06

then bronchial provocation tests can be

play09:09

done which are not commonly performed

play09:10

and if they were performed then the a

play09:13

decrease in fev1 by 20 percent is

play09:16

diagnostic for asthma so in the

play09:19

diagnosis typical clinical features with

play09:22

demonstration of reversible

play09:23

bronchoconstriction on pfts bronchial

play09:25

provocation test as a second line test

play09:27

this is how you make the diagnosis of

play09:30

asthma now there is one another point

play09:32

that I want to mention here that when

play09:34

you receive a patient with an asymmetic

play09:36

attack and you perform spirometry and

play09:38

the spirometry shows results like this

play09:39

decrease fev1 to fvc ratio in such case

play09:43

COPD patients also have the same pattern

play09:46

on spirometry now how will you

play09:49

differentiate that whether it is COPD or

play09:52

it is asthma one important thing in the

play09:54

clinical history would be that COPD

play09:57

always have a baseline disease COPD

play10:00

patients usually have a baseline disease

play10:02

Baseline obstruction all the time and in

play10:05

between they get the exacerbations in

play10:08

asthma patients will say that I was

play10:10

totally

play10:13

Leaf of the days but sometimes I so

play10:15

we're just tightness and difficulty

play10:17

breathing so that is one important Point

play10:19

other than that for academic purposes

play10:21

you can also remember that there is a

play10:24

bronchodilator reversibility test now if

play10:26

the patient is having a difficulty

play10:28

shortness of breath chest tightness you

play10:31

do you suspect that that patient is

play10:33

having asthma you perform spirometer you

play10:35

get results like this then what you can

play10:37

do is that you can give bronchodilator

play10:39

challenge you can give bronchodilator to

play10:42

the patient like albuterol 200 to 400

play10:44

microgram now when you give Alberta role

play10:47

to the patient that albuterol will cause

play10:48

bronchodilation and that bronchodilation

play10:51

will make it easier for a patient for a

play10:53

stomatic patient to breathe to Exhale

play10:55

the air out

play10:57

so when you perform the spirometry now

play11:00

after giving the bronchodilator they

play11:01

will be greater than 12 percent

play11:03

increased in the forced expired volume

play11:05

in the first second

play11:07

but in COPD patient there will not be as

play11:10

much change there will be no improvement

play11:13

even after giving bronchodilators

play11:15

so if you are confused at whether that

play11:18

patient is having COPD or asthma in that

play11:21

case you can perform bronchodilator

play11:22

reversibility test so a patient comes to

play11:24

you in your clinic with chest tightness

play11:26

with shortness of breath you suspect

play11:28

asthma you perform spirometry if the

play11:30

spirometry it shows decrease ref1 FEC

play11:33

and you suspect that that patient is

play11:35

having asthma or COPD you can perform

play11:38

bronchodilator reversibility now coming

play11:40

to the classification of s my according

play11:42

to the National asthma education and

play11:44

prevention program the classes of asthma

play11:46

include intermittent asthma persistent

play11:49

asthma persistent asthma is further

play11:50

divided into three categories mild

play11:52

persistent moderate persistent and

play11:54

severe persistent asthma

play11:56

now we'll discuss each one of them in

play11:59

detail the how are they classified on

play12:01

the basis of their symptoms and their

play12:03

treatment with each category first

play12:05

coming to the intermittent asthma a

play12:07

patient is said to have intermittent

play12:09

asthma if the patient experiences

play12:11

symptoms of bronchoconstriction asthma

play12:14

frequency less than two times a week

play12:17

waking up because of symptoms at night

play12:20

less than two times are equal to two

play12:22

times a month use of short acting beta

play12:26

Agonist drugs short technique beta

play12:27

Agonist drugs are the drugs that are

play12:29

present in the inhalers that cause

play12:30

bronchodilation less than or equal to

play12:33

two days per week so you can remember

play12:35

the word two these classes are basically

play12:38

categorized based on the symptoms with

play12:40

which the patient presents so if the

play12:42

symptoms are slightly Mild they are

play12:44

classified into intermittent asthma and

play12:46

when you perform spirometry on these

play12:48

patients the force expiratory volume is

play12:50

greater than or equal to 80 percent of

play12:51

the expected which is a normal value

play12:53

so these patients are not having that

play12:55

severe asthma that their fev1 is

play12:57

deranged but they develop the shortness

play12:59

of breath they develop difficulty

play13:01

breathing sometimes

play13:03

exacerbation requiring steroids less

play13:06

than one time a year

play13:08

now how do you treat these patients with

play13:10

intermittent asthma these intermittent

play13:12

asthma patients are treated with just

play13:13

Saba inhaler short acting beta Agonist

play13:17

inhalers these beta Agonist drugs are

play13:19

contained in these containers and they

play13:21

cause bronchodilation drugs like

play13:23

albuterol are short acting beta agonists

play13:26

inhaled albuterol 90 microgram per puff

play13:29

now what you do is that you ask the

play13:31

patient that whenever you feel chest

play13:33

tightness whenever you feel shortness of

play13:35

breath what you do is that you take the

play13:37

inhaler you shake the inhaler first and

play13:40

then you exhale the air out then you

play13:43

hold it around your mouth tightly and

play13:46

you inhale through your mouth at the

play13:49

same time press the inhaler

play13:51

and then you should stop breathing for

play13:54

at least 10 seconds you should hold the

play13:56

breath for 10 seconds and after 10

play13:58

seconds you can exhale through your

play13:59

mouth

play14:00

so that there is effective drug

play14:02

absorption within the lungs two to four

play14:05

Puffs as needed whenever the patient has

play14:08

anastomatic attack daily therapy is not

play14:11

required it is just a rescue inhaler

play14:14

rescue inhaler means that whenever

play14:15

patient feels an attack of asthma

play14:17

whenever patient feels that he is having

play14:19

shortness of breath at that time patient

play14:21

will use this inhaler daily therapy is

play14:24

not recommended in patients with

play14:26

intermittent asthma they will just have

play14:28

to use these rescue inhalers only

play14:30

whenever they feel chest tightness

play14:32

difficulty in breathing whenever they

play14:34

feel they are having asthmatic attack

play14:35

they just use these rescue inhalers

play14:37

otherwise no drilling inhalers no daily

play14:39

use drugs are prescribed 2020 Gina

play14:43

guidelines recommended to add low dose

play14:46

inhaled corticosterides for daily

play14:48

therapy now coming to persistent asthma

play14:51

persistent asthma is further divided

play14:53

into three categories mild persistent

play14:55

moderate persistent severe persistent

play14:57

we'll discuss that how are they

play14:58

classified then we'll discuss the

play14:59

treatment of each one of these mild

play15:01

persistent if the patient is having

play15:03

symptoms greater than two times a week

play15:05

waking up at night three to four times

play15:08

per month with minor limitation of daily

play15:10

activities

play15:12

moderate persistent asthma is the one

play15:14

when the patient is having symptoms of

play15:16

asthma daily waking up for greater than

play15:19

one time a week

play15:21

some limitation of activity of daily

play15:24

life in severe persistent asthma patient

play15:27

will be having daily symptoms throughout

play15:29

the day it's a severe form of asthma

play15:31

waking up every night because of

play15:33

difficulty in breathing and there is

play15:34

Extreme limitation of activity that

play15:36

patient cannot exercise that patient

play15:38

cannot perform the daily life activity

play15:40

because he is I mean getting severe

play15:42

attack of asthma again and again now

play15:44

when you perform spirometry on these

play15:46

patients what you would see is that the

play15:48

spirometry results will be normal in

play15:50

mild persistent asthma and feb1 will be

play15:52

greater than 80 percent whenever the

play15:53

fev1 is greater than 80 percent of the

play15:55

predictive value it's normal but when it

play15:58

is less than 80 it's abnormal in

play16:00

moderate persistent it's from 60 to 80

play16:02

percent of the predicted in the severe

play16:04

persistent it will be even less than 60

play16:06

percent which is a severe form of asthma

play16:08

now coming to treatment of each one of

play16:10

these in the treatment of mild

play16:11

persistent asthma you give the daily

play16:14

therapy in intermittent asthma daily

play16:17

therapy was not recommended only Gina

play16:19

guidelines recommended that you can add

play16:21

low dose inhered corticosteroids in mild

play16:24

persistent asthma daily therapy is

play16:26

recommended with low dose inhaled

play16:28

corticosteroids in helicorticosteroids

play16:30

include productionide fluticasone

play16:33

other Alternatives that can be used for

play16:35

daily therapy include leukotriene

play16:38

receptor antagonist as I said that

play16:40

leucotrans cause bronchoconstriction so

play16:42

we antagonize them with leukotriene

play16:44

receptor antagonists like Montelukast

play16:47

zaphast these are leukotriene receptor

play16:50

antagonists and they can be prescribed

play16:52

to patients as for daily therapy in mild

play16:54

persistent asthma and whenever the

play16:57

patient gets attack you ask the patient

play17:00

to use the short acting beta Agonist

play17:02

albuterol inhaler as I showed you in the

play17:04

previous picture so whenever it gets

play17:06

patient gets the attack patient uses

play17:08

sub-inl otherwise daily patient is using

play17:11

inhale corticosteroid inhaler as a daily

play17:13

therapy now coming to the moderate

play17:16

persistent asthma and the treatment of

play17:17

moderate persistent asthma it is a more

play17:19

severe form of asthma and in which you

play17:21

have to give daily therapy with inhalers

play17:24

that contain ludos inhaled

play17:26

corticosteroid and for metrol for mitral

play17:29

is basically long acting bit Agonist now

play17:32

remember one thing that short acting

play17:34

beta Agonist inhalers can be given alone

play17:36

but long-acting beta Agonist inhalers

play17:38

can never be given alone they are given

play17:41

which steroids combination

play17:43

so for Mid role is given with a

play17:45

combination of inhaled corticosteroid

play17:47

preferably a single inhaler and that

play17:49

patient uses that single inhaler as a

play17:52

daily therapy as well as as a rescue

play17:54

therapy whenever patient gets attack

play17:56

patient uses that in otherwise patient

play17:58

also uses that in another daily

play18:01

now remember as I said that there are

play18:03

two important components in the

play18:04

pathogenesis of asthma one is bronchial

play18:07

inflammation and the other one is

play18:09

bronchial constriction the inhibit

play18:11

Agonist inhalers control the

play18:14

bronchoconstriction they call

play18:15

bronchodilation

play18:16

and the steroids they reduce the

play18:19

inflammation so you we are treating the

play18:22

both components of asthma other

play18:25

combinations include inhaled

play18:27

corticosteroids with long-acting bit

play18:28

agonists other than format role inhaled

play18:30

corticosteroids in combination with long

play18:33

acting muscarinic antagonists inhaled

play18:36

corticosterides with leukotriene

play18:38

receptor antagonists and you can add

play18:40

Saba if you are using the last two

play18:43

otherwise if you are giving inhaled

play18:45

corticosteroid with four meter roll

play18:47

inhaler in a single inhaler you can give

play18:49

it as a daily therapy as well as a

play18:50

rescue therapy you did not need to add

play18:52

Sabah into this

play18:54

now coming to severe persistent asthma

play18:56

so we are persistent as much as a severe

play18:58

form of asthma and in this condition you

play19:00

need to give inhaled corticosteroids

play19:02

with long-acting beta Agonist and long

play19:04

acting muscarinic antagonists inhaled

play19:08

corticosteroids include buddhistonide

play19:09

and proticason long-acting beta agonists

play19:13

include format role and long-acting

play19:15

muscarinic antagonists muscarinic

play19:17

antagonists are the drugs that block the

play19:20

action of parasympathetics some

play19:22

parasympathetic system causes

play19:23

bronchoconstriction and if you are

play19:24

blocking the parasympathetic system

play19:26

which results in bronchodilation and

play19:28

they include diode propion bromide

play19:30

and with this combination you give

play19:33

rescue inhaler Saba whenever the patient

play19:35

gets attacked patient uses saba and as a

play19:39

daily therapy patient uses these drugs

play19:42

if the patient's asthma is still not

play19:44

controlled what you need to do is that

play19:46

you can add oral corticosteroids now we

play19:49

were avoiding oral corticosteroids

play19:51

throughout but in severe persistent

play19:52

asthma which is not controlled with the

play19:54

inhale drug you need to add oral

play19:56

corticosteroids because in severe

play19:59

persistent asthma there is severe

play20:00

inflammation there is a severe

play20:02

disability of the patient who cannot

play20:04

perform the real life activities every

play20:06

night patient is waking up with an

play20:08

asymmetic attack you need to add oral

play20:09

corticosters if it is not controlled

play20:11

with inhale drugs with that you need to

play20:14

give inhaled corticosteroids and long

play20:16

acting beta Agonist

play20:18

now coming to some general Myers in a

play20:20

patient who is being treated for asthma

play20:22

what you need to do is that you need to

play20:23

do medication review if the patient is

play20:25

taking beta blockers remember beta

play20:28

blockers are contraindicated in patients

play20:30

with asthma if you are ever prescribing

play20:32

beta blockers to a patient you must ask

play20:35

any history of asthma if the patient is

play20:37

having any history of asthma then beta

play20:39

blockers are contraindicated other than

play20:40

that NSAIDs as I said that NSAIDs

play20:43

increase leukotrans and leucotrans cause

play20:45

bronchoconstriction you ask the patient

play20:47

to avoid allergen patients really knows

play20:49

that which thing he is allergic to and

play20:51

asks them to use impermeable pillow

play20:53

covers bed sheets treat the comorbs and

play20:56

if the patient is having good treated

play20:58

with proton pump inhibitors smoking

play21:00

cessation is most and highly important

play21:03

very important for patients with asthma

play21:05

and you teach the patient use of peak

play21:07

flow meter this is a picture showing

play21:09

Peak flow meter in which they exhale the

play21:11

air and see how much air they are

play21:13

exhaling out

play21:15

whenever the patient has an asthma

play21:16

attack they can exhale out less air and

play21:19

they can see that by themselves at home

play21:21

and when they take the inhaler they can

play21:24

even see the improvement with Peak flow

play21:26

meter so you teach the patients use of

play21:29

peak flow meter and I have also made a

play21:31

video on the treatment of strata

play21:32

systematic as if a patient gets severe

play21:34

status asthematicus attack how do you

play21:36

manage it I have talked about it in

play21:38

detail in my video on status

play21:39

systematicus management you can check

play21:41

out the link in the description below

play21:42

now in the follow-up when you have

play21:44

started the therapy you ask the patient

play21:46

to come back in two or four weeks and

play21:48

you check the symptom frequency that by

play21:50

the symptom frequency has decreased or

play21:52

not you see that whether is the patient

play21:54

has decreased frequency of developing

play21:56

excess abations and you do pfts and if

play22:00

the patient is improving then after some

play22:02

stable period you can consider step down

play22:04

therapy now in some patients who are

play22:07

again and again coming to you and they

play22:09

are not getting better with the

play22:10

treatment even with the Step Up therapy

play22:12

when you are adding more drugs the

play22:14

patients are not getting better now

play22:16

whenever you are going for a step up

play22:18

therapy when you are going to add a drug

play22:19

remember to see that whether that

play22:21

patient is compliant with the treatment

play22:23

or not and also assists the inhaler

play22:25

technique many patients do not even know

play22:27

that how to use inhaler and they are

play22:29

technically wasting drug they are not

play22:31

even using that inhaler properly teach

play22:33

them to use inhaler properly and if they

play22:35

cannot use the inhaler properly ask them

play22:38

to use spacer this is a picture of

play22:41

spacer spacer is a device that is

play22:43

attached with the inhaler and patient

play22:46

inhales the drug from this part now the

play22:49

good thing about spacer is that if the

play22:51

patient misses the drug in one breath

play22:54

the drug is not wasted the drug is

play22:57

present in the inhaler and that patient

play22:59

can in inhale it in second or third

play23:01

breath now briefly coming to the side

play23:03

effects of the drugs used in treatment

play23:05

of asthma inhaled corticosterides the

play23:08

inhalers that contain corticosteroids

play23:10

cause oral candidiasis remember as a

play23:13

patient that whenever they use inhaler

play23:15

that contain corticosterite they must

play23:18

rinse their mouth with water

play23:20

short-acting beta Agonist most commonly

play23:23

cause slight tremor

play23:25

oral corticosteroids can cause diabetes

play23:28

mellitus cataract osteoporosis adrenal

play23:31

suppression of steroids therefore we

play23:33

reserve the oral corticosteroids for

play23:35

very severe asthma if the very end we

play23:38

give it to the patients an interesting

play23:40

tidbit in the past grimald cigarettes

play23:44

were prescribed to the patients with

play23:46

asthma these grimald cigarettes used to

play23:48

contain atropine in it atropine is an

play23:51

anticholinergic which causes

play23:52

bronchodilation other than that they

play23:55

used to contain cannabis in it the Tura

play23:57

in it so they were this is an ad that is

play24:01

recommending used for of grimald

play24:04

cigarettes for asthma bronchial trouble

play24:06

hey fever and laryngitis but now after

play24:09

all this research we know how much the

play24:11

tobacco is dangerous for a patient with

play24:14

asthma smoking cessation is most

play24:15

important thing for a patient with

play24:17

asthma the first best intervention that

play24:20

you can do is in an asthma patient is to

play24:22

tell them to stop smoking cigarettes

play24:25

this is just an interesting fact from

play24:27

the past

play24:29

in summary we talked about what is

play24:31

asthma the triggers of asthma the

play24:33

symptoms the diagnosis with pfts the

play24:36

classification the intermittent asthma

play24:39

and the treatment of intermittent asthma

play24:41

moderate mild persistent moderate

play24:43

persistence severe persistent asthma and

play24:45

their treatments the general Meyers the

play24:48

follow-up causes of inadequate response

play24:51

side effects of the drugs used for

play24:53

asthma if you liked my video please

play24:55

click on the Subscribe button and check

play24:57

out my other videos on emergency

play24:58

medicine and pulmonology lectures the

play25:01

link of those videos is given in the

play25:03

description below thank you very much

Rate This
β˜…
β˜…
β˜…
β˜…
β˜…

5.0 / 5 (0 votes)

Related Tags
AsthmaPulmonologyRespiratoryDiagnosisTreatmentAllergiesBronchodilationChest TightnessSpirometryCOPD